RBR Evidence Summary: <strong>Pneumococcal conjugate vaccine</strong>

Pneumococcal conjugate vaccine

Pneumococcal vaccine: conjugate (Pneu-C-13) and polysaccharide (Pneu-P-23):

Recommended schedule, number of doses, and product depend on the age of the child, risk for pneumococcal disease, and when vaccination is begun. Consult NACI guidelines.

Routine infant immunization: administer three doses of Pneu-C-13 vaccine at minimum 8-week intervals beginning at 2 months of age, followed by a fourth dose at 12 to 15 months of age. For healthy infants, a three-dose schedule may be used, with doses at 2 months, 4 months, and 12 months of age.

Children 2 years and above who are at highest risk of invasive pneumococcal disease should receive Pneu-P-23. Consult NACI guidelines for eligibility and dosing schedule.

Pneu-C-15 or Pneu-C-20 are now available and are being used in some jurisdictions instead of Pneu-C-13. See NACI for details including products, doses, and timing.

Parent Resources

Caring For Kids - Canadian Paediatric Society (CPS)

Pneumococcal Vaccine - Canadian Paediatric Society – Caring for Kids

Other Sources

Immunization information. - Immunize Canada